StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Puma Biotechnology (PBYI) PT Raised to $37 at RBC Capital
March 1, 2019 6:51 AM
RBC Capital analyst Kennen MacKay raised the price target on Puma Biotechnology (NASDAQ: PBYI) to $37.00 (from $29.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Puma Biotech (PBYI) Surges Following Results; Analyst Sees Few Excuses Not to Own
March 1, 2019 10:51 AM
Puma Biotechnology (PBYI) PT Raised to $70 at Citi
March 1, 2019 5:02 AM
After-Hours Movers 02/28: (GPS) (PBYI) (FNKO) Higher; (MRSN) (NTNX) (TSLA) (more...)
February 28, 2019 5:58 PM
Form 8-K PUMA BIOTECHNOLOGY, INC. For: Feb 28
February 28, 2019 4:14 PM
Puma Biotech (PBYI) Misses Q4 EPS by 3c
February 28, 2019 4:11 PM
Puma Biotechnology Reports Fourth Quarter and Full Year 2018 Financial Results
February 28, 2019 4:09 PM
